Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

10,11-methylenedioxycamptothecin

Known as: MDCPT cpd 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
This study designs an alternative transdermal delivery system for 10,11-methylenedioxycamptothecin(MD-CPT) to inhibit keloid… Expand
2004
2004
Camptothecin (CPT) analogs that form more stable ternary complexes with DNA and topoisomerase I (termed cleavable complexes) show… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2001
2001
UCN-01 is a hydroxylated derivative of staurosporine and a potent protein kinase C (PKC) inhibitor. Interest in the potential… Expand
1996
1996
20(S)‐Camptothecin (CPT), a topoisomerase I inhibitor specifically toxic toward S‐phase cells, was tested topically for its… Expand
Highly Cited
1995
Highly Cited
1995
Camptothecins belong to a group of anticancer agents with a specific mechanism of action: stabilization and trapping of… Expand
Highly Cited
1993
Highly Cited
1993
The cytotoxic alkaloid camptothecin (CPT) and several of its analogues, including the clinically relevant topotecan (TPT… Expand
1991
1991
Previous studies in rapidly proliferating rodent cells have suggested that the lethal effect of the DNA topoisomerase I inhibitor… Expand
1990
1990
We had previously shown that 10,11-methylenedioxy-20-(RS)-camptothecin (MDO-CPT) is a more potent inhibitor of purified DNA… Expand